Chargement en cours...
Influenza virus polymerase inhibitors in clinical development
PURPOSE OF REVIEW: We review antivirals inhibiting subunits of the influenza polymerase complex that are advancing in clinical development. RECENT FINDINGS: Favipiravir, pimodivir, and baloxavir are inhibitory in preclinical models for influenza A viruses, including pandemic threat viruses and those...
Enregistré dans:
| Publié dans: | Curr Opin Infect Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6416007/ https://ncbi.nlm.nih.gov/pubmed/30724789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QCO.0000000000000532 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|